References

Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

10.1016/s0140-6736(17)32448-0 · 2017 · External reference

Natural history of pediatric Crohn’s disease: a population-based cohort study

10.1053/j.gastro.2008.06.079 · 2008 · External reference

Inflammatory bowel disease in young people

10.1002/ibd.21145 · 2010 · External reference

A product review of vedolizumab in inflammatory bowel disease

10.1080/21645515.2019.1591139 · 2019 · External reference

Development and validation of the mucosal inflammation noninvasive index for pediatric Crohn’s disease

10.1016/j.cgh.2019.04.012 · 2020 · External reference

Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study

10.1016/s2468-1253(24)00319-4 · 2025 · External reference

Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study

10.1016/s2468-1253(22)00307-7 · 2023 · External reference

Metabolomics insights into inflammatory bowel disease: a comprehensive review

10.3390/ph14111190 · 2021 · External reference

Microbiome-modulated metabolites at the interface of host immunity

10.4049/jimmunol.1601247 · 2017 · External reference

Faecal and serum metabolomics in paediatric inflammatory bowel disease

10.1093/ecco-jcc/jjw158 · 2017 · External reference

Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies

10.3748/wjg.v20.i12.3231 · 2014 · External reference

Chemical composition of commercial cow’s milk

10.1021/acs.jafc.9b00204 · 2019 · External reference

The bovine metabolome

10.3390/metabo10060233 · 2020 · External reference

A bi-objective K-nearest-neighbors-based imputation method for multilevel data

10.1016/j.eswa.2022.117298 · 2022 · External reference

Minimum redundancy feature selection from microarray gene expression data

10.1142/s0219720005001004 · 2005 · External reference

Permutation tests for studying classifier performance

2010 · External reference

The malic acid inhibiting inflammation in ankylosing spondylitis by interfering M1 macrophage polarization

10.1016/j.intimp.2024.113653 · 2025 · External reference

Maternal malic acid may ameliorate oxidative stress and inflammation in sows through modulating gut microbiota and host metabolic profiles during late pregnancy

10.3390/antiox13020253 · 2024 · External reference

Malic enzyme 3 mediated the effects of malic acid on intestinal redox status and feed efficiency in broilers

10.1186/s40104-025-01163-3 · 2025 · External reference

Citric acid promotes immune function by modulating the intestinal barrier

10.3390/ijms25021239 · 2024 · External reference

Citric acid promoting B lymphocyte differentiation and anti-epithelial cells apoptosis mediate the protective effects of Hermetia illucens feed in ETEC induced piglets diarrhea

10.3389/fvets.2021.751861 · 2021 · External reference

Potential role of the common food additive manufactured citric acid in eliciting significant inflammatory reactions contributing to serious disease states: a series of four case reports

10.1016/j.toxrep.2018.08.002 · 2018 · External reference

Citrus fruits and their flavonoids in inflammatory bowel disease: an overview

10.1080/14786419.2019.1601196 · 2020 · External reference

Dimethyl fumarate reduces inflammatory responses in experimental colitis

10.1093/ecco-jcc/jjv231 · 2016 · External reference

Discovery of novel imidazo[4,5- c] quinoline derivatives to treat inflammatory bowel disease (IBD) by inhibiting multiple proinflammatory signaling pathways and restoring intestinal homeostasis

10.1021/acs.jmedchem.2c00390 · 2022 · External reference

Possible effects of uremic toxins p-cresol, indoxyl sulfate, p-cresyl sulfate on the development and progression of colon cancer in patients with chronic renal failure

10.3390/genes14061257 · 2023 · External reference

Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoelectrospray-tandem mass spectrometry

10.1080/00365520410006233 · 2004 · External reference

Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: a clue to pathogenesis

10.1002/ibd.20993 · 2009 · External reference

The mechanisms of lysophosphatidylcholine in the development of diseases

10.1016/j.lfs.2020.117443 · 2020 · External reference

Metabolomic analysis of skin biopsies from patients with atopic dermatitis reveals hallmarks of inflammation, disrupted barrier function and oxidative stress

10.2340/00015555-3766 · 2021 · External reference

Alteration of sphingolipids in biofluids: implications for neurodegenerative diseases

10.3390/ijms20143564 · 2019 · External reference

Roles of short-chain fatty acids in inflammatory bowel disease

10.3390/nu15204466 · 2023 · External reference

Tryptophan metabolism through the kynurenine pathway is associated with endoscopic inflammation in ulcerative colitis

10.1093/ibd/izy103 · 2018 · External reference

The role of 5-HT dysregulation in inflammatory bowel disease

2013 · External reference

Serum concentrations of 7α-hydroxy-4-cholesten-3-one are associated with bile acid diarrhea in patients with Crohn’s disease

10.1016/j.cgh.2018.11.012 · 2019 · External reference